Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Fut7em1/Cya
Common Name:
Fut7-KO
Product ID:
S-KO-02133
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Fut7-KO
Strain ID
KOCMP-14347-Fut7-B6J-VA
Gene Name
Fut7
Product ID
S-KO-02133
Gene Alias
FTVII; Fuc-TVII; FucT-VII
Background
C57BL/6JCya
NCBI ID
14347
Modification
Conventional knockout
Chromosome
2
Phenotype
MGI:107692
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Fut7em1/Cya mice (Catalog S-KO-02133) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000100320
NCBI RefSeq
NM_001177366
Target Region
Exon 1~2
Size of Effective Region
~3.6 kb
Detailed Document
Click here to download >>
Overview of Gene Research
FUT7, also known as fucosyltransferase VII or α1,3-Fucosyltransferase 7, is an enzyme that catalyzes the addition of fucose residues to glycoproteins and glycolipids, specifically involved in the synthesis of selectin ligands through α1,3-fucosylation. This process is crucial for cell-cell adhesion, immune cell trafficking, and inflammation regulation [7,8].

FUT7 has been found to play significant roles in multiple diseases. In bladder urothelial carcinoma (BLCA), its up-regulation promotes epithelial-mesenchymal transition (EMT) and immune infiltration, and patients with high FUT7 levels have lower survival rates [1]. In acute lymphoblastic leukemia (ALL), although the relevant paper was retracted [6], the original study suggested that FUT7 promoted cell adhesion and invasion through the integrin/FAK/AKT pathway [2]. In follicular thyroid carcinoma (FTC), FUT7 overexpression enhances cell proliferation, EMT, migration, and invasion by catalyzing the α1,3-fucosylation of epidermal growth factor receptor (EGFR) [3]. In lung cancer, FUT7 hypomethylation in blood may serve as a biomarker for early-stage detection [4,5]. In hereditary multiple exostoses, a missense mutation in FUT7 affects its cellular localization, regulates cell proliferation, and interacts with EXT1 in chondrocyte regulation [9].

In conclusion, FUT7 is essential for processes related to cell-cell adhesion and immune response. Its dysregulation is associated with various cancers and a skeletal disorder. Studies on FUT7, potentially including gene knockout or knockdown models in the future, contribute to understanding disease mechanisms and may offer new diagnostic and therapeutic targets for related diseases.

References:

1. Liu, Mulin, Zheng, Qin, Chen, Siyi, Liu, Jiwei, Li, Shijun. 2021. FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma. In Journal of inflammation research, 14, 1069-1084. doi:10.2147/JIR.S296597. https://pubmed.ncbi.nlm.nih.gov/33790621/

2. He, Fei, Yi, Lijun, Lai, Changcheng. 2022. Fut7 Promotes Adhesion and Invasion of Acute Lymphoblastic Leukemia Cells through the Integrin/Fak/Akt Pathway. In Evidence-based complementary and alternative medicine : eCAM, 2022, 1864116. doi:10.1155/2022/1864116. https://pubmed.ncbi.nlm.nih.gov/35795270/

3. Qin, Huamin, Liu, Jianwei, Yu, Ming, Yan, Qiu, Wang, Lifen. 2020. FUT7 promotes the malignant transformation of follicular thyroid carcinoma through α1,3-fucosylation of EGF receptor. In Experimental cell research, 393, 112095. doi:10.1016/j.yexcr.2020.112095. https://pubmed.ncbi.nlm.nih.gov/32442537/

4. Qiao, Rong, Di, Feifei, Wang, Jun, Han, Baohui, Yang, Rongxi. 2023. Identification of FUT7 hypomethylation as the blood biomarker in the prediction of early-stage lung cancer. In Journal of genetics and genomics = Yi chuan xue bao, 50, 573-581. doi:10.1016/j.jgg.2023.02.014. https://pubmed.ncbi.nlm.nih.gov/36898609/

5. Fang, Yifei, Qu, Yunhui, Ji, Longtao, Dai, Liping, Ouyang, Songyun. 2022. Novel blood-based FUT7 DNA methylation is associated with lung cancer: especially for lung squamous cell carcinoma. In Clinical epigenetics, 14, 167. doi:10.1186/s13148-022-01389-2. https://pubmed.ncbi.nlm.nih.gov/36463240/

6. And Alternative Medicine, Evidence-Based Complementary. 2023. Retracted: Fut7 Promotes Adhesion and Invasion of Acute Lymphoblastic Leukemia Cells through the Integrin/Fak/Akt Pathway. In Evidence-based complementary and alternative medicine : eCAM, 2023, 9786508. doi:10.1155/2023/9786508. https://pubmed.ncbi.nlm.nih.gov/37829639/

7. Wu, Chia-Hsien, Inoue, Tsuyoshi, Nakamura, Yasuna, Nangaku, Masaomi, Inagi, Reiko. 2021. Activation of α7 nicotinic acetylcholine receptors attenuates monocyte-endothelial adhesion through FUT7 inhibition. In Biochemical and biophysical research communications, 590, 89-96. doi:10.1016/j.bbrc.2021.12.094. https://pubmed.ncbi.nlm.nih.gov/34973535/

8. Zhang, Jun, Ju, Nana, Yang, Xi, Chen, Linmu, Yu, Chao. 2017. The α1,3-fucosyltransferase FUT7 regulates IL-1β-induced monocyte-endothelial adhesion via fucosylation of endomucin. In Life sciences, 192, 231-237. doi:10.1016/j.lfs.2017.11.017. https://pubmed.ncbi.nlm.nih.gov/29138114/

9. Peng, Wan, Li, Gao-Fei, Lin, Guo-Wang, Xie, Xian-Biao, Bei, Jin-Xin. 2024. Identification of novel germline mutations in FUT7 and EXT1 linked with hereditary multiple exostoses. In Oncogene, 44, 835-848. doi:10.1038/s41388-024-03254-3. https://pubmed.ncbi.nlm.nih.gov/39690272/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest